AI brief
Pathos AI Inc. raised $237 million in a Series E round at a $3 billion valuation, led by Bristol Myers Squibb with participation from unnamed returning backers.
Written by AI from SiliconANGLE AI's published text.
Background
From our own funding, model and news trackers, not from the source.
Pathos
- Latest funding
- Growth · $237M · 23 Oct 2026
- Last 30 days
- 1 news story
Source
“Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers.”
Reporting from a publisher outside the organisation being covered.
Read original story ↗